Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
sglt2-drugs
Press Release
Jul 21, 2015
Federal Regulators Warn of Diabetic Ketoacidosis Side Effects of Invokana and SGLT2 Inhibitors
Federal regulators are warning consumers and the medical community that a potentially life-threatening condition called diabetic ketoacidosis may be linked to a popular class of diabetes drugs known as SGLT2 (sodium-glucose cotransporter-2) inhibitors.
Read More
First
Prev
1
Next
Last
